We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$227M
AUM Growth
-$15.9M
Cap. Flow
-$6.57M
Cap. Flow %
-2.89%
Top 10 Hldgs %
7.9%
Holding
407
New
8
Increased
60
Reduced
329
Closed
10

Top Buys

Rank Stock Value
1
XFLT
XAI Floating Rate & Alternative Income Trust
XFLT
+$689K
2
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
+$551K
3
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
+$468K
4
ENIC icon
Enel Chile
ENIC
+$430K
5
EFT
Eaton Vance Floating-Rate Income Trust
EFT
+$429K

Top Sells

Rank Stock Value
1
GRA
W.R. Grace & Co.
GRA
+$1.73M
2
BGX
Blackstone Long-Short Credit Income Fund
BGX
+$731K
3
BGB
Blackstone Strategic Credit 2027 Term Fund
BGB
+$693K
4
NOA
North American Construction
NOA
+$554K
5
MCI
Barings Corporate Investors
MCI
+$524K

Sector Composition

Rank Sector Weight
1 Healthcare 25.28%
2 Real Estate 19.7%
3 Energy 13.28%
4 Utilities 12%
5 Materials 10.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
376
Pliant Therapeutics
PLRX
$66.3M
$109K 0.05%
6,466
-333
-5% -$7.07K
HARP
377
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$109K 0.05%
1,377
-72
-5% -$7.24K
ALGS icon
378
Aligos Therapeutics
ALGS
$26.3M
$106K 0.05%
273
-14
-5% -$5.54K
AXSM icon
379
Axsome Therapeutics
AXSM
$12.1B
$104K 0.05%
3,146
-167
-5% -$6.51K
HYD icon
380
VanEck High Yield Muni ETF
HYD
$4.45B
$104K 0.05%
1,669
-1,581
-49% -$100K
LONA
381
LeonaBio Inc
LONA
$65.5M
$103K 0.05%
1,096
-57
-5% -$5.8K
TCRR
382
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$100K 0.04%
11,762
-617
-5% -$8.72K
PRTK
383
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$99K 0.04%
20,379
-1,068
-5% -$5.89K
BTX
384
BlackRock Technology and Private Equity Term Trust
BTX
$919M
$97K 0.04%
+5,361
New +$104K
ORTX
385
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$97K 0.04%
4,226
-221
-5% -$6.58K
PTGX icon
386
Protagonist Therapeutics
PTGX
$8.8B
$92K 0.04%
5,170
-271
-5% -$11.6K
EVLO
387
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$92K 0.04%
651
-34
-5% -$6.74K
KYNB
388
Kyntra Bio
KYNB
$28.2M
$84K 0.04%
329
-18
-5% -$6.38K
ANVS icon
389
Annovis Bio
ANVS
$71.9M
$76K 0.03%
2,387
-131
-5% -$7.53K
IRON icon
390
Disc Medicine
IRON
$2.85B
$76K 0.03%
623
-33
-5% -$4.51K
MCRB icon
391
Seres Therapeutics
MCRB
$46.5M
$72K 0.03%
515
-26
-5% -$5.09K
SPRY icon
392
ARS Pharmaceuticals
SPRY
$563M
$64K 0.03%
6,371
-330
-5% -$8.14K
EPIX
393
DELISTED
ESSA Pharma
EPIX
$63K 0.03%
7,826
-407
-5% -$6.47K
HGEN
394
DELISTED
HUMANIGEN, INC.
HGEN
$61K 0.03%
10,355
-546
-5% -$7.67K
CARM
395
DELISTED
Carisma Therapeutics
CARM
$40K 0.02%
2,501
-131
-5% -$6.29K
ARDX icon
396
Ardelyx
ARDX
$1.25B
$38K 0.02%
28,694
-1,493
-5% -$3.99K
FBRX icon
397
Forte Biosciences
FBRX
$1.57B
$15K 0.01%
209
-11
-5% -$6.09K
BGB
398
Blackstone Strategic Credit 2027 Term Fund
BGB
$500M
– –
-49,719
Closed -$693K
BGX
399
Blackstone Long-Short Credit Income Fund
BGX
$136M
– –
-48,335
Closed -$731K
BKLN icon
400
Invesco Senior Loan ETF
BKLN
$6.97B
– –
-6,778
Closed -$150K
13 14 15
16
17

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Virtus ETF Advisers held 407 positions worth $227M, down 6.5% from $243M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.4%. Virtus ETF Advisers opened 8 new positions and exited 10, leaving the 407-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Real Estate and Energy.

  • Virtus ETF Advisers's largest Q3 2021 buy was XAI Floating Rate & Alternative Income Trust: 15,447 shares worth $663K.
  • Virtus ETF Advisers added most to Enel Chile in Q3 2021, an estimated $430K increase.
  • Virtus ETF Advisers's biggest Q3 2021 reduction was North American Construction, cutting an estimated $554K.
  • Virtus ETF Advisers fully exited W.R. Grace & Co. in Q3 2021, selling an estimated $1.73M.
  • Virtus ETF Advisers's ten largest holdings make up 7.9% of its $227M portfolio in Q3 2021.
  • Virtus ETF Advisers opened 8 new positions and closed 10 in Q3 2021.
  • Virtus ETF Advisers's portfolio value fell 6.5% quarter-over-quarter to $227M.

Based on Virtus ETF Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.